Financials

  • Market Capitalization 80.29 M
  • Employee 13
  • Founded 2018
  • CEO N/A
  • Website www.maiabiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG0113Q7J88
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
4024
GOSS
Gossamer Bio, Inc. - Common Stock
0.17 USD0.00%+13.33%-5.56%-92.98%83.10 M USD
4036
ATHE
Alterity Therapeutics Limited - American Depositary Shares
4.51 USD-1.10%-3.01%+1.12%-19.32%81.75 M USD
4058
TENX
Tenax Therapeutics, Inc. - Common Stock
2.13 USD-2.74%+25.29%-85.84%-71.79%79.71 M USD
4066
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.14 USD-4.20%+0.88%-8.80%-12.31%78.40 M USD

MAIA Biotechnology, Inc. Common Stock

MAIA Biotechnology, Inc. 是一家总部位于伊利诺伊州芝加哥的上市免疫肿瘤学公司,专注于开发针对端粒的药物,用于治疗端粒酶阳性癌细胞。

新闻